Literature DB >> 17729351

Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction.

Arne Skjold1, Brage H Amundsen, Rune Wiseth, Asbjørn Støylen, Olav Haraldseth, Henrik B W Larsson, Per Jynge.   

Abstract

PURPOSE: To evaluate contrast accumulation in left ventricular (LV) myocardium after manganese dipyridoxyl-diphosphate (MnDPDP) administration in patients with recent first time myocardial infarction.
MATERIALS AND METHODS: MnDPDP (5 micromol/kg) was administered to 10 patients with recent myocardial infarction (three to 12 weeks). One slice of interest (SOI) likely to traverse the infarction was chosen, and sectorial pre- and postcontrast longitudinal relaxivity rates (R(1)) and signal changes during infusion were estimated with a fast gradient echo sequence. LV volume and wall thickening were measured in short-axis cine recordings. Infarct localization from R(1) and wall thickening data were compared by vector analyses.
RESULTS: Reduced wall thickening was associated with reduced precontrast R(1) and reduced contrast enhancement. Both remote and infarcted regions showed rapid initial contrast accumulation. In remote regions, this was followed by a continuing slow increase. Mean precontrast R(1) was 0.87 +/- 0.06 second(-1) in infarcted regions and 0.96 +/- 0.03 second(-1) in remote regions (P < 0.001). Mean R(1) change over one hour was 0.24 +/- 0.07 second(-1) in infarcted regions and 0.38 +/- 0.03 second(-1) in remote regions (P < 0.0001).
CONCLUSION: Remote regions showed larger increases in R(1) than infarcted regions. This is most likely due to selective and slow Mn accumulation in viable myocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729351     DOI: 10.1002/jmri.21065

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  16 in total

1.  Manganese-based MRI contrast agents: past, present and future.

Authors:  Dipanjan Pan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Tetrahedron       Date:  2011-11-04       Impact factor: 2.457

Review 2.  Methods to assess stem cell lineage, fate and function.

Authors:  Patricia K Nguyen; Divya Nag; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2010-09-09       Impact factor: 15.470

Review 3.  Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.

Authors:  Mohamed Aissiou; Delphine Périé; Farida Cheriet; Nagib S Dahdah; Caroline Laverdière; Daniel Curnier
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-07       Impact factor: 2.357

4.  Anatomy, Functionality, and Neuronal Connectivity with Manganese Radiotracers for Positron Emission Tomography.

Authors:  Galit Saar; Corina M Millo; Lawrence P Szajek; Jeff Bacon; Peter Herscovitch; Alan P Koretsky
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

5.  A rapid T1 mapping method for assessment of murine kidney viability using dynamic manganese-enhanced magnetic resonance imaging.

Authors:  Kai Jiang; Hui Tang; Prasanna K Mishra; Slobodan I Macura; Lilach O Lerman
Journal:  Magn Reson Med       Date:  2017-11-28       Impact factor: 4.668

6.  Toward clinical application of manganese-enhanced MRI of retinal function.

Authors:  Paul S Tofts; Andre Porchia; Ying Jin; Robin Roberts; Bruce A Berkowitz
Journal:  Brain Res Bull       Date:  2009-06-11       Impact factor: 4.077

7.  Preliminary assessment of cardiac short term safety and efficacy of manganese chloride for cardiovascular magnetic resonance in humans.

Authors:  Juliano L Fernandes; Pippa Storey; Jose Alvaro da Silva; Gabriel S de Figueiredo; Jose M Kalaf; Otavio R Coelho
Journal:  J Cardiovasc Magn Reson       Date:  2011-01-14       Impact factor: 5.364

8.  Manganese-Enhanced T1 Mapping in the Myocardium of Normal and Infarcted Hearts.

Authors:  N B Spath; D M L Lilburn; G A Gray; L M Le Page; G Papanastasiou; R J Lennen; R L Janiczek; M R Dweck; D E Newby; P C Yang; M A Jansen; S I Semple
Journal:  Contrast Media Mol Imaging       Date:  2018-10-25       Impact factor: 3.161

9.  Assessment of stunned and viable myocardium using manganese-enhanced MRI.

Authors:  Nick B Spath; Trisha Singh; Giorgos Papanastasiou; Andrew Baker; Rob J Janiczek; Gerry P McCann; Marc R Dweck; Lucy Kershaw; David E Newby; Scott Semple
Journal:  Open Heart       Date:  2021-06

10.  Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat.

Authors:  Ismail Ben Mosbah; Yann Mouchel; Julie Pajaud; Catherine Ribault; Catherine Lucas; Alexis Laurent; Karim Boudjema; Fabrice Morel; Anne Corlu; Philippe Compagnon
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.